IBIO (STOCKS)
iBio, Inc. Common Stock
$1.660000
-0.030000 (-1.78%)
Prev close: $1.690000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- CEO
- Martin B. Brenner
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $82.22M
- Employees
- 20
- P/E (TTM)
- -2.86
- P/B (TTM)
- 0.75
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
7
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q3)
|
$-0.07 | $-0.06 | -0.0061 | -9.55% |
|
Dec 2025 (Q2)
|
$-0.09 | $-0.08 | -0.0058 | -6.89% |
|
Sep 2025 (Q1)
|
$-0.11 | $-0.10 | -0.0054 | -5.16% |
|
Mar 2025 (Q4)
|
$-0.49 | $-0.37 | -0.1177 | -31.61% |
Financial Statements
| Revenues | $300.00K |
| Benefits Costs and Expenses | $9.13M |
| Costs And Expenses | $28.13M |
| Nonoperating Income/Loss | $1.35M |
| Operating Expenses | $29.26M |
| Research and Development | $14.31M |
| Other Operating Expenses | $14.95M |
| Operating Income/Loss | -$28.96M |
| Income/Loss From Continuing Operations After Tax | -$27.61M |
| Income/Loss From Continuing Operations Before Tax | -$8.83M |
| Income Tax Expense/Benefit | -$8.54M |
| Net Income/Loss | -$27.61M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$27.61M |
| Net Income/Loss Available To Common Stockholders, Basic | -$27.61M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.56 |
| Diluted Earnings Per Share | -$0.56 |
| Basic Average Shares | 196,927,000 |
| Diluted Average Shares | 196,927,000 |
| Assets | $85.83M |
| Current Assets | $77.25M |
| Noncurrent Assets | $8.58M |
| Fixed Assets | $3.31M |
| Intangible Assets | $1.83M |
| Non-current Prepaid Expenses | $282.00K |
| Other Non-current Assets | $3.16M |
| Liabilities | $8.30M |
| Current Liabilities | $6.50M |
| Accounts Payable | $3.04M |
| Other Current Liabilities | $3.47M |
| Noncurrent Liabilities | $1.79M |
| Equity | $77.54M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $77.54M |
| Liabilities And Equity | $85.83M |
| Net Cash Flow From Operating Activities | -$21.61M |
| Net Cash Flow From Operating Activities, Continuing | -$21.61M |
| Net Cash Flow From Investing Activities | -$27.54M |
| Net Cash Flow From Investing Activities, Continuing | -$27.54M |
| Net Cash Flow From Financing Activities | $91.82M |
| Net Cash Flow From Financing Activities, Continuing | $91.82M |
| Net Cash Flow | $42.68M |
| Net Cash Flow, Continuing | $42.68M |
| Comprehensive Income/Loss | -$27.63M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$27.63M |
| Other Comprehensive Income/Loss | -$7.75M |